Health

Johnson & Johnson vaccine awaiting approval from the FDA

The Johnson & Johnson vaccine, which would require only one shot unlike the Pfizer-BionNTech and Moderna- vaccine, is awaiting approval from the food and drug administration (FDA). If it's granted approval, it would be distributed among American states in the coming weeks.  An executive from the company said it expects to move almost 4 million doses when it gets approval from the FDA.  Johnson & Johnson vaccine will improve US vaccination efforts  The vaccine-if approved- will greatly boost the chances of the United States in battling the coronavirus pandemic and improving its economy... Learn more...